Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer

Cancer Research

Volumn 72, Issue 17, 2012, Pages 4311-4317

  Kreisel, Daniel ^a,b   Gelman, Andrew E ^a   Higashikubo, Ryuji ^a   Lin, Xue ^a   Vikis, Haris G ^c   White, J Michael ^a   Toth, Kelsey A ^a   Deshpande, Charuhas ^d   Carreno, Beatriz M ^a,b   You, Ming ^b,c   Taffner, Samantha M ^a   Yokoyama, Wayne M ^a,e   Bui, Jack D ^f   Schreiber, Robert D ^a,b   Krupnick, Alexander S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; CD8 ANTIGEN; NEUROKININ 1 RECEPTOR ANTAGONIST; URETHAN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RESISTANCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONGENIC STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; GENE STRUCTURE; GENETIC VARIABILITY; HEMATOPOIETIC CELL; IMMUNOSURVEILLANCE; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; LUNG CANCER; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; STRAIN DIFFERENCE; TUMOR PROMOTION;

ADAPTIVE IMMUNITY; ANIMALS; BONE MARROW CELLS; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CHROMOSOMES; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC SURVEILLANCE; INFLAMMATION; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMORPHISM, GENETIC; SPECIES SPECIFICITY; URETHANE;

EID: 84865794098     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-0908     Document Type: Article

References (20)

1. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011;29:235-71.
2. Zhang Z, Futamura M, Vikis HG, Wang M, Li J, Wang Y, et al. Positional cloning of the major quantitative trait locus underlying lung tumor susceptibility in mice. Proc Natl Acad Sci U S A 2003;100:12642-7.
3. Wang M, Zhang Z, Vikis H, Yan Y, Wang Y, You M. Fine mapping and candidate gene analyses of pulmonary adenoma resistance 1, a major genetic determinant of mouse lung adenoma resistance. Cancer Res 2007;67:2508-16.
4. Wang D, You M. Five loci, SLT1 to SLT5, controlling the susceptibility to spontaneously occurring lung cancer in mice. Cancer Res 2005;65:8158-65.
5. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7.
6. Liu P, Wang Y, Vikis H, Maciag A, Wang D, Lu Y, et al. Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nat Genet 2006;38:888-95.
7. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107-11.
8. Brown MG, Scalzo AA, Stone LR, Clark PY, Du Y, Palanca B, et al. Natural killer gene complex (Nkc) allelic variability in inbred mice: evidence for Nkc haplotypes. Immunogenetics 2001;53:584-91.
9. Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007;450:903-7.
10. DuPage M, Dooley AL, Jacks T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 2009;4:1064-72.
11. IARC. Overall evaluation of carcinogenicity. In: IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Lyon, France: IARC; 1987. p. 440.
12. Malkinson AM. Role of inflammation in mouse lung tumorigenesis: a review. Exp Lung Res 2005;31:57-82.
13. Derbyshire K, Addey C, Coe D, Stuckey DW, Muezzin H, Bubier JA, et al. Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration. J Immunol 2011;186:5719-28.
14. Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, Festing MF, et al. Genealogies of mouse inbred strains. Nat Genet 2000;24:23-5.
15. Whyte AL, Miller SC. Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice. Immunobiology 1998;199:23-38.
16. Gorelik E, Herberman RB. Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity. J Natl Cancer Inst 1981;67:1317-22.
17. McVicar DW, Winkler-Pickett R, Taylor LS, Makrigiannis A, Bennett M, Anderson SK, et al. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J Immunol 2002;169:1721-8.
18. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003;3:304-16.
19. Higuchi DA, Cahan P, Gao J, Ferris ST, Poursine-Laurent J, Graubert TA, et al. Structural variation of the mouse natural killer gene complex. Genes Immun 2010;11:637-48.
20. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, et al. RAG-2-deficientmice lackmature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992;68:855-67.